A Study on the Correlation Between Oral Health and Delirium in Surgical Inpatients
1 other identifier
observational
550
1 country
1
Brief Summary
Delirium is a clinical syndrome characterized by acute attention deficits, altered consciousness, and fluctuating cognitive dysfunction, typically triggered by multifactorial causes such as physical illness, medication use, or postoperative stress . As the most common complication in hospitalized patients, delirium is highly prevalent among elderly surgical populations, with postoperative delirium (POD) occurring in 7.5%-27.5% of cases, and rates rising to 50%-70% in intensive care unit (ICU) patients . Its onset is closely associated with poor prognoses, including long-term postoperative cognitive decline , increased mortality, prolonged hospitalization, and elevated healthcare costs (annual costs in the United States ranging from 38billionto152 billion) . Early prevention and screening of POD are therefore critical to improving patient outcomes and reducing healthcare burdens. Surgical patients' oral health issues exhibit multifactorial pathogenesis: intrinsic factors (e.g., age-related tooth loss, malnutrition-induced mucosal repair impairment, and chewing dysfunction due to reduced skeletal muscle mass) and iatrogenic factors (e.g., endotracheal intubation trauma, salivary secretion suppression from analgesics, and inadequate perioperative oral care). Poor oral health in hospitalized patients is often attributable to aging, physical dependence, cognitive decline, malnutrition, low skeletal muscle mass/strength, and comorbidities. The recently proposed concept of "Oral Frailty"-a progressive decline in oral structure and function-strongly predicts physical frailty, dysphagia, malnutrition, long-term care needs, and mortality in community-dwelling older adults The impact of oral health on cognitive function may involve three pathways : Mechanical pathway: Tooth loss disrupts masticatory motor function, reduces cerebral blood flow, and diminishes afferent stimulation from peripheral receptors (e.g., periodontal ligaments), leading to weakened neural connectivity and regional brain atrophy. Neurodegenerative pathway: Tooth loss accelerates neuronal damage via apoptosis and mitophagy, increasing amyloid-beta deposition in the brain. Inflammatory/metabolic pathway: Systemic inflammation, metabolic dysregulation, microbial-gut-brain axis interactions, and activation of microglia/astrocytes drive neuroinflammatory cascades in the central nervous system. Given these connections, oral frailty may act as an independent risk factor distinct from general frailty and a potential contributor to POD. These findings suggest that oral frailty could serve as a unique biomarker for perioperative neurocognitive disorders, mediating their pathogenesis. Systematic investigation into the spatiotemporal relationship and mechanisms linking oral health to POD in surgical patients holds significant clinical value for developing multimodal prevention strategies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 26, 2025
CompletedFirst Posted
Study publicly available on registry
May 13, 2025
CompletedStudy Start
First participant enrolled
May 25, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 25, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 25, 2026
CompletedMay 13, 2025
April 1, 2025
10 months
April 26, 2025
May 6, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Delirium
First, assess the patient's consciousness using the Richmond Agitation-Sedation Scale (RASS). This scale categorizes sedation levels into 10 grades, ranging from +4 (combative) to -5 (comatose), with each score corresponding to a distinct state of consciousness. Next, perform delirium assessment using the Confusion Assessment Method for the ICU (CAM-ICU).he Chinese version of CAM-ICU evaluates delirium through four domains: * fluctuating Mental Status ②Attention Deficits * Disorganized Thinking ④Altered Consciousness Clarity A delirium diagnosis is confirmed if criteria ① and ② are met, along with either ③ and/or ④. Consciousness comprises two components: arousal level and awareness content. To assess delirium, begin by evaluating arousal level using the RASS. If the patient's RASS score is not -4 or -5 (indicating adequate arousal), proceed with delirium evaluation.
Within One Week Postoperatively
Secondary Outcomes (3)
dysphagia
48 hours after removal of the endotracheal tube
appetite
48 hours after removal of the endotracheal tube
Serum albumin
Postoperative serum albumin levels are routinely assessed within the first week after surgery.
Study Arms (2)
Oral Frailty Group
Non-Oral Frailty Group
Interventions
The exposure factor is the presence of oral frailty in patients before surgery, and oral frailty is evaluated using a scale.
Eligibility Criteria
Patients scheduled for elective cardiac surgery under general anesthesia requiring endotracheal intubation
You may qualify if:
- Patients aged ≥18 years scheduled for elective cardiac or thoracic surgery requiring endotracheal intubation.
- Patients without consciousness impairment, able to cooperate with the investigation.
- Patients or their legal guardians informed about the study's purpose, methodology, and content, with signed informed consent forms.
You may not qualify if:
- Patients with pre-existing oral conditions (e.g., xerostomia, oral mucosal lesions) prior to mechanical ventilation.
- Patients with a history of radiotherapy, chemotherapy, or corticosteroid use before surgery.
- Patients experiencing intraoperative mortality.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shanghai Xinhua hospital
Shanghai, Shanghai Municipality, 200092, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 26, 2025
First Posted
May 13, 2025
Study Start
May 25, 2025
Primary Completion
March 25, 2026
Study Completion
March 25, 2026
Last Updated
May 13, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share